| The Effects of GSTM1 and GSTT1 Polymorphisms on Micronucleus Frequencies in Human Lymphocytes In vivo M Kirsch-Volders, RA Mateuca, M Roelants, A Tremp, E Zeiger, S Bonassi, ... Cancer Epidemiology Biomarkers & Prevention 15 (5), 1038-1042, 2006 | 445 | 2006 |
| References for growth and pubertal development from birth to 21 years in Flanders, Belgium M Roelants, R Hauspie, K Hoppenbrouwers Annals of human biology 36 (6), 680-694, 2009 | 410 | 2009 |
| Overweight and obesity in Norwegian children: prevalence and socio‐demographic risk factors PB Júlíusson, GE Eide, M Roelants, PE Waaler, R Hauspie, R Bjerknes Acta paediatrica 99 (6), 900-905, 2010 | 236 | 2010 |
| The value of CAGE, CUGE, and AUDIT in screening for alcohol abuse and dependence among college freshmen B Aertgeerts, F Buntinx, J Bande‐Knops, C Vanderrneulen, M Roelants, ... Alcoholism: Clinical and Experimental Research 24 (1), 53-57, 2000 | 197 | 2000 |
| Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs LGE Hanem, S Stridsklev, PB Júlíusson, Ø Salvesen, M Roelants, ... The Journal of Clinical Endocrinology & Metabolism 103 (4), 1612-1621, 2018 | 190 | 2018 |
| Growth references for 0–19 year-old Norwegian children for length/height, weight, body mass index and head circumference PB Júlíusson, M Roelants, E Nordal, L Furevik, GE Eide, D Moster, ... Annals of human biology 40 (3), 220-227, 2013 | 187 | 2013 |
| Semen quality of young adult ICSI offspring: the first results F Belva, M Bonduelle, M Roelants, D Michielsen, A Van Steirteghem, ... Human Reproduction 31 (12), 2811-2820, 2016 | 177 | 2016 |
| Outbreak of mumps in a vaccinated child population: a question of vaccine failure? C Vandermeulen, M Roelants, M Vermoere, K Roseeuw, P Goubau, ... Vaccine 22 (21-22), 2713-2716, 2004 | 162 | 2004 |
| Waist circumference and waist‐to‐height ratio in Norwegian children 4–18 years of age: Reference values and cut‐off levels B Brannsether, M Roelants, R Bjerknes, PB Júlíusson Acta paediatrica 100 (12), 1576-1582, 2011 | 160 | 2011 |
| Growth of Belgian and Norwegian children compared to the WHO growth standards: prevalence below− 2 and above+ 2 SD and the effect of breastfeeding PB Júlíusson, M Roelants, K Hoppenbrouwers, R Hauspie, R Bjerknes Archives of disease in childhood 96 (10), 916-921, 2011 | 149 | 2011 |
| Overweight and obesity in Norwegian children: secular trends in weight‐for‐height and skinfolds PB Júlíusson, M Roelants, GE Eide, R Hauspie, PE Waaler, R Bjerknes Acta Paediatrica 96 (9), 1333-1337, 2007 | 134 | 2007 |
| Influenza and pertussis vaccination coverage in pregnant women J Laenen, M Roelants, R Devlieger, C Vandermeulen Vaccine 33 (18), 2125-2131, 2015 | 126 | 2015 |
| Personalized approach to growth hormone treatment: clinical use of growth prediction models JM Wit, MB Ranke, K Albertsson-Wikland, A Carrascosa, RG Rosenfeld, ... Hormone research in paediatrics 79 (5), 257-270, 2013 | 109 | 2013 |
| Growth charts for Norwegian children PB Júlíusson, M Roelants, GE Eide, D Moster, A Juul, R Hauspie, ... Tidsskrift for Den norske legeforening, 2009 | 109 | 2009 |
| Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer F Belva, M Bonduelle, M Roelants, G Verheyen, L Van Landuyt Human Reproduction 31 (7), 1610-1620, 2016 | 108 | 2016 |
| Important periods of weight development in childhood: a population-based longitudinal study K Glavin, M Roelants, BH Strand, PB Júlíusson, KK Lie, S Helseth, ... BMC public health 14, 1-8, 2014 | 106 | 2014 |
| Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models L Gonzalez, LCJ Thomassen, G Plas, V Rabolli, D Napierska, I Decordier, ... Nanotoxicology 4 (4), 382-395, 2010 | 106 | 2010 |
| Are ICSI adolescents at risk for increased adiposity? F Belva, R Painter, M Bonduelle, M Roelants, P Devroey, J De Schepper Human reproduction 27 (1), 257-264, 2012 | 103 | 2012 |
| Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey H Theeten, N Hens, C Vandermeulen, AM Depoorter, M Roelants, M Aerts, ... Vaccine 25 (26), 4940-4948, 2007 | 101 | 2007 |
| Timeliness of infant vaccination and factors related with delay in Flanders, Belgium T Lernout, H Theeten, N Hens, T Braeckman, M Roelants, ... Vaccine 32 (2), 284-289, 2014 | 87 | 2014 |
